Loading news...
AvePoint, Inc. (NASDAQ: AVPT - Get Free Report) Chairman Xunkai Gong sold 32,002 shares of the stock in a transaction on Monday, January 12th. The shares were sold at an average price of $13.66, for a total value of $437,147.32. Following the completion of the transaction, the chairman owned 14,948,666 shares of the company's stock, valued
AvePoint, Inc. (NASDAQ: AVPT - Get Free Report) Chairman Xunkai Gong sold 27,998 shares of the company's stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $13.39, for a total value of $374,893.22. Following the completion of the transaction, the chairman directly owned 14,920,668 shares of
AvePoint, Inc. (NASDAQ: AVPT - Get Free Report) shares were down 5.4% during trading on Friday. The company traded as low as $13.26 and last traded at $13.1450. Approximately 199,468 shares traded hands during trading, a decline of 91% from the average daily volume of 2,249,910 shares. The stock had previously closed at $13.89. Analyst
The fund increased holding by 3,243,910 shares, while the reported position value decreased by $22.98 million. The transaction represented 11.27% of the fund's reportable U.S. equity assets under management (AUM).
Pre-Market Stock Futures: The futures are trading flat after investors and traders returned from the Christmas holiday to find a lump of coal in their stockings. All the major indices closed lower on Monday, with the technology sector leading the way on end-of-year profit-taking. With only one full trading day left in 2025 and the... Here Are Tuesday's Top Wall Street Analyst Research Calls: Alphabet, Applied Digital, Birkenstock, Etsy, Genius Sports, Tesla, Twilio, and More.
The consensus price target hints at a 46.8% upside potential for AvePoint (AVPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
AvePoint (NASDAQ: AVPT - Get Free Report) and Cannasys (OTCMKTS:MJTK - Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Earnings and Valuation This table compares AvePoint and
AvePoint, Inc. is a specialized SaaS provider for data governance and protection on Microsoft 365 and other collaborative cloud platforms. AVPT's recurring revenue reached 87%, with ARR at $327M and operating margins turning positive, reflecting strong SaaS-driven operating leverage. I rate AVPT a cautious Buy due to high valuation multiples, Microsoft ecosystem dependence, and sector competition, but see 40% upside if execution continues.
Federated Hermes Inc. lessened its stake in AvePoint, Inc. (NASDAQ: AVPT) by 27.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 654,772 shares of the company's stock after selling 252,162 shares during the period. Federated Hermes Inc. owned about
AvePoint, Inc. (AVPT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The consensus price target hints at a 49.3% upside potential for AvePoint (AVPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AvePoint, Inc. (AVPT) Presents at UBS Global Technology and AI Conference 2025 Transcript
In the most recent quarter, AVPT's revenue climbed by 23.56% y/y to $109.7 million; profitability for the period improved, with operating income margin expanding to 10.09% from 8.62% last year. AVPT is set to benefit from the AI-driven data explosion, as enterprises increasingly outsource data governance and compliance needs. AVPT aims to diversify beyond Microsoft, targeting 30% of revenue from non-Microsoft products by FY2029 and expanding its channel partner ecosystem.
AgentPulse adds to AvePoint's growing AI agent governance capabilities in the Confidence Platform, providing more visibility to reduce security risks and costs AgentPulse adds to AvePoint's growing AI agent governance capabilities in the Confidence Platform, providing more visibility to reduce security risks and costs
AvePoint (AVPT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ROKU, AVPT, ETOR, NRIM and OPRX have been added to the Zacks Rank #1 (Strong Buy) List on November 17, 2025.
Shares of AvePoint, Inc. (NASDAQ: AVPT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fourteen analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating, eight have given a buy rating and one
JERSEY CITY, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in data security, governance and resilience, today announced that members of the Company's executive management team will present at the following investor conferences: Wells Fargo 9th Annual TMT Summit (Rancho Palos Verdes, CA): 11/18 at 12:45pm PT RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference (New York, NY): 11/18 at 4:00pm ET UBS Global Technology and AI Conference (Scottsdale, AZ): 12/2 at 12:55pm PT In addition, AvePoint will attend: 6th Annual Needham Tech Week (Virtual): 11/24 Northland Capital Markets Growth Conference (Virtual): 12/16 A live and archived audio webcast of all presentations will be available on the AvePoint Investor Relations website.
Although the revenue and EPS for AvePoint (AVPT) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.